LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.
Logotheti S, Marquardt S, Gupta SK, Richter C, Edelhäuser BAH, Engelmann D, Brenmoehl J, Söhnchen C, Murr N, Alpers M, Singh KP, Wolkenhauer O, Heckl D, Spitschak A, Pützer BM.
Logotheti S, et al. Among authors: spitschak a.
Theranostics. 2020 Jul 29;10(21):9620-9643. doi: 10.7150/thno.44176. eCollection 2020.
Theranostics. 2020.
PMID: 32863950
Free PMC article.